Total Funding
4
18
Total FundingDebt Financing raised
Growth Score
-8 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
378715
Arcion Therapeutics is a biotechnology company developing treatments for chronic pain.
William Schmidt: Vice President Clinical & Regulatory
James N. Campbell: Chief Executive OfficerPast Role: InterWest Partners, Executive-in-Residence
About the Company
Arcion Therapeutics, Inc., a biotechnology company, focuses on the development of treatments for severe pain. It offers a pipeline of products for the treatment of painful diabetic neuropathy, post-herpetic neuralgia, and various forms of moderate and severe pain. The company was incorporated in 2007 and is based in Baltimore, Maryland.
